Magda Michna
Chief Development Officer @STAAR Surgical
Signup · Get unlimited contacts
WORK HISTORY
Chief Development Officer @STAAR Surgical
Lake Forest, CA, US
Honored to lead outstanding teams in global clinical, medical, and regulatory affairs, as well as R&D, and quality, and drive the company’s strategic growth by ensuring the development of innovative products that deliver impact.Shaping the direction of clinical trials, regulatory submissions, medical strategies, and quality management systems across multiple global markets is only possible through fostering collaboration with our ophthalmic community and guiding the organization in bringing cutting-edge technologies to market while navigating the complexities of international regulations and clinical needs.https://eyewire.news/news/staar-surgical-announces-restructure-of-leadership?c4src=article:infinite-scroll
EDUCATION
University of California, San Francisco
Drug Development and Regulatory Sciences
University of Melbourne
Doctor of Philosophy - PhD, Optics/Optical Sciences
SKILLS
ABOUT MAGDA MICHNA
With more than two decades of leadership in ophthalmic innovation, my career has centered on building development organizations that transform scientific insight into durable clinical and commercial impact. Leading the full continuum of product development—clinical, medical affairs, regulatory, quality, R&D, and advanced research—we can unite critical disciplines around a single objective: accelerating meaningful innovation to patients worldwide.The most successful medical technologies emerge when evidence generation, regulatory strategy, and product design evolve together rather than in sequence. By integrating these functions early, we reduce risk, shorten development timelines, and create platforms that are not only approvable, but scalable, defensible, and clinically transformative.This philosophy enabled landmark achievements such as the US FDA approval of the IC-8® Apthera™ intraocular lens, which we delivered through a globally coordinated clinical and regulatory strategy. More importantly, it reflects a broader vision—one where development organizations move beyond execution to become strategic engines of growth, shaping the future of eye care through disciplined innovation, scientific rigor, and patient-centered design.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.